|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.70 USD | -0.84% |
|
-8.22% | -18.61% |
| 02-23 | Gilead to buy cancer therapy developer Arcellx for up to $7.8 billion | RE |
| 02-12 | Legend Biotech Shares Lower After Rothschild & Co Redburn Downgrade | MT |
6243c485d6f6320d3638044bfaae15.XVGuIZFebEvb7blR1utGLV3q8OR7BGz5_gUjt06exVM.HjXLEqULASKevfs6gKkFcmiFwZQKdC2opldS3jzOphtkFdxmwB8gDpih7A~871ce5dd0deccde15df6903316ed1e68
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition